Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 334 of 6351
-
New combo therapy aims to tackle Hard-to-Treat blood cancers
Disease control Recruiting nowThis phase II trial studies how well the addition of nemtabrutinib to lisocabtagene maraleucel in treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) that has come back after a period of improvement (relapsed) or that does not respond to treat…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Old drug, new hope? emetine trial targets dengue deaths
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy and safety of emetine administered orally for symptomatic patients aged 18-65 years infected with the dengue virus. The main questions it aims to answer are: 1. Does emetine reduce 28-day mortality or progression to severe dengu…
Phase 2/3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New scan could spare throat cancer patients from unnecessary radiation side effects
Disease control Not yet recruitingOropharyngeal cancer (OPC) is the most common type of head and neck cancer. The current standard treatment for this cancer is radiotherapy (RT) of the tumour and lymph nodes of both sides of the neck, combined with concurrent chemotherapy for advanced stages. Even though a small …
Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill aims to curb focal seizures in adults
Disease control Recruiting nowThis is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
Phase 3 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
30,000 seniors to wear heart patches in massive Stroke-Prevention study
Diagnosis Not yet recruitingThis prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of …
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New antibody drug aims to save Insulin-Making cells in type 1 diabetes
Disease control Not yet recruitingThis Phase 3, multicenter, randomized, double-blind, placebo-controlled study will evaluate the efficacy, safety, and tolerability of SAB-142, a fully human anti-thymocyte globulin (h-ATG), in participants aged 5 to 40 years with Stage 3 type 1 diabetes (T1D). The study will enro…
Phase 3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Gene therapy injection aims to halt blinding eye disease
Disease control Not yet recruitingThe goals of this interventional study are (1) to evaluate the safety and tolerability of multiple doses of PST-611 in men and women over the age of 65 with geographic atrophy secondary to age-related macular degeneration and (2) to assess efficacy of multiple doses of PST-611 by…
Phase 2 • Sponsor: Eyevensys • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a wearable muscle sensor replace X-Rays for scoliosis?
Diagnosis Not yet recruitingThis study aims to develop and evaluate a wireless, non-invasive, embedded electromyography (EMG) system for monitoring paraspinal muscle activation asymmetries in adolescents with idiopathic scoliosis. Surface EMG electrodes will be placed bilaterally around the apical vertebra …
Sponsor: Ertugrul Deniz Kose • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
Olive oil compounds may shield the aging brain from memory decline
Prevention Not yet recruitingThe goal of this clinical trial is to determine whether the extra-virgin olive oil (EVOO) phenolic dietary supplement can improve memory function and modulate biomarkers among individuals with mild cognitive impairment (MCI). The main questions it aims to answer are: * Does diet…
Sponsor: Augusta University • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Rising from a fall: a new skill to save seniors?
Prevention Not yet recruitingFalls among older adults are a major public health issue, accounting for approximately 2 million incidents annually in France, resulting in more than 10,000 deaths and 130,000 hospitalizations. Their cost is estimated at nearly 2 billion euros per year and is expected to rise as …
Sponsor: Centre Hospitalier Emile Roux • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Sound waves and microbubbles: a new key to the Brain's locked door?
Disease control Not yet recruitingCAMPSIS is a preliminary feasibility study of the TheraOne medical device (IIb). TheraOne is an active, non-invasive medical device intended to deliver transcranial FUS in combination with intravenous microbubbles in order to transiently and locally induce the BBB permeability. …
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
SWAT officers test ketone drink for Stress-Proof thinking
Symptom relief Recruiting nowThe goal of this study is to determine whether consuming a commercially available exogenous ketone supplement (KetoneIQ®) affects cognition, specifically marksmanship, under physical stress (i.e., exhaustive exercise). The main questions we seek to answer are: * Does the supple…
Sponsor: Florida State University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Virtual reality could rewire the mind for better spine surgery recovery
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a virtual reality-based cognitive behavioral therapy (VR-CBT) prehabilitation program can improve recovery and quality of life for adults undergoing elective spine surgery. The main questions it aims to answer are: Does partici…
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advance…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a targeted drug tame neuroendocrine tumors in everyday practice?
Disease control Not yet recruitingPrior clinical trials have demonstrated promising efficacy and manageable safety of surufatinib in neuroendocrine tumors (NETs). This real-world study aims to evaluate the clinical efficacy and safety of surufatinib in patients with NETs, providing additional real-world evidence …
Sponsor: Yefeng • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Citrus extract may curb menopause belly fat
Disease control Not yet recruitingThe menopausal transition is associated with significant hormonal and metabolic changes, primarily driven by a decline in estrogen levels. These changes contribute to alterations in body composition, including an increase in total body fat, preferential accumulation of central an…
Sponsor: DR Healthcare - biotexia • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
A gentle zap to the ankle might restore bladder control after spinal injury
Symptom relief Not yet recruitingThis is a prospective, single-arm, pilot study to assess effectiveness and tolerability of transcutaneous tibial nerve stimulation (TTNS) in managing neurogenic detrusor overactivity in spinal cord injury patients. 12 - 16 spinal cord injury patients with neurogenic detrusor over…
Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can alcohol boost the power of nerve blocks for sweaty palms?
Disease control Not yet recruitingPalmar hyperhidrosis is a medical condition characterized by excessive sweating specifically from the palms of the hands. This condition can significantly impact an individual's quality of life, leading to social embarrassment, anxiety, and difficulties in daily activities. It is…
Sponsor: Fayoum University Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A diet tweak may boost platelets in a bleeding disorder
Disease control Not yet recruitingThis randomized controlled trial aims to evaluate the effect of a selective Mediterranean diet regimen, used as an adjunct to standard therapy, on platelet count and bleeding-related outcomes in adult patients with primary immune thrombocytopenia (ITP).
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new injection help tackle obesity? a trial puts it to the test
Disease control Not yet recruitingThe main purpose of this study is to assess how well LY4329090 is tolerated and what side effects may occur in healthy participants with obesity or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the bo…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC